Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Making LDL Matter Again: Addressing Clinical, Patient, and Payer Barriers in ASCVD Management
home / stakeholder-summit / making-ldl-matter-again-addressing-clinical-patient-and-payer-barriers-in-ascvd-management
Panelists discuss how persistent undertreatment, shifting guidelines, therapy access barriers, and economic burden all contribute to poor LDL-C control, underscoring the need for renewed focus on outcomes-driven strategies to reduce cardiovascular risk.
Nihar Desai, MD, MPH;Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC;Steven Kheloussi, PharmD, MBA, FAMCP;Joseph Saseen, PharmD, BCPS, BCACP, CLS
October 31st 2025Panelists discuss how: LDL-C control remains a national crisis, with many patients not on therapy or failing to reach target levels despite the availability of effective treatments.
Watch
EP. 2: Challenges with Undertreatment in Hyperlipidemia and Opportunities to Address this Gap
Nihar Desai, MD, MPH;Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC;Steven Kheloussi, PharmD, MBA, FAMCP;Joseph Saseen, PharmD, BCPS, BCACP, CLS
October 31st 2025Panelists discuss how: clinical inertia, patient apathy, and the asymptomatic nature of high cholesterol all contribute to undertreatment and poor outcomes.
Watch
